companydata.dkcompanydata.dk

DERMA PHARM A/S: Financial statements 2017

CVR: 89453119

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 47,585,869 and a net result of DKK 8,607,895 compared with DKK 7,769,435 the year before. That is an increase of 10.2% compared with the year before. Equity in the 2017 report amounted to DKK 31,009,111. The solvency ratio was 48.4%. The company had 71 employees in the financial year.

Gross Profit
DKK 47,585,869
Profit/Loss
DKK 8,607,895
Equity
DKK 31,009,111
Total Assets
DKK 64,128,276
Employees
71

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-47.6 mio.8.6 mio.31 mio.71
2016-43.2 mio.7.8 mio.22.4 mio.62
2015-33.3 mio.4.3 mio.14.6 mio.56
2014-24.2 mio.-4.3 mio.10.3 mio.-
2013-29.8 mio.1.6 mio.14.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on DERMA PHARM A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

DERMA PHARM A/S: The 2016 annual report is outJun 10, 2017

DERMA PHARM A/S has published its annual report for 2016. Gross profit came to DKK 43,171,388, and the net result was DKK 7,769,435.

Peter Bogh joins DERMA PHARM A/S as directorApr 5, 2017

As of April 5, 2017, Peter Bogh is registered as director of DERMA PHARM A/S.

About DERMA PHARM A/S

DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.

Source: annual report 2025, Danish Business Authority